Healthcare & Pharma top picks: AI and personalization fuel new era of health innovation
Older updates:
EDGE Insights
Revolutionizing healthcare: The power of GenAI
EDGE Insights
2024 US elections impact on emerging industries: Winners and losers of a Democratic presidency
EDGE Insights
Sustainable E-Waste Management
EDGE Insights
Gumroad: The online check-out platform for creators
EDGE Insights
Airwallex: The global FinTech for cross-border transactions and virtual multi-currency accounts
EDGE Insights
Airbyte: The open-source data integration platform
EDGE Insights
Census: Bridging data warehouses and SaaS apps through reverse ETL
EDGE Interview
Exa CEO Will Bryk on building search for AI agents
EDGE Insights
Automated Restaurants
EDGE Insights
Workato: The enterprise automations platform with low/no-code capabilities
By Abdul Azeez, Jehan Saldin · May 20, 2024
Healthcare & Pharma top picks: AI and personalization fuel new era of health innovation
In the past two editions, the framework has identified the most promising startups in emerging industries, equipping innovators with the knowledge to identify the best companies before they reach product maturity.
Drugs discovered by AI are nearing commercialization, as candidates advance through the clinical pipeline. Most notably, Insilico Medicine successfully moved its lead drug candidate into Phase II clinical trials, making it the first AI-discovered drug to reach this stage of human clinical trials. Meanwhile, Exscientia also advanced two of its four drug candidates into Phase I/II clinical trials.
Healthcare & Pharma startups are increasingly focused on offering tailored therapeutics using novel methods such as nanopore sequencing (Oxford Nanopore) and analyzing data from wearable devices (Movano Health) and patient healthcare records (Atropos Health) to gather individual-level insights into patients. This approach enables them to develop personalized health plans and therapeutics to better treat patients.
Gene treatments hold immense potential in the healthcare space, with companies such as CRISPR Therapeutics pioneering human gene editing techniques and showing promise for treating genetic disorders by accurately altering problematic genes. Meanwhile, Autolus is leading the charge in cell and gene therapy, leveraging advanced cell programming technologies to develop cutting-edge treatments that harness the body's immune system to combat diseases like cancer.
SPEEDA Edge top picks for 2024
Source: SPEEDA Edge
Contact us
Gain access to all industry hubs, market maps, research tools, and more
Get a demo
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.